As to the market conditions there can be doubt they are changing. I have an etrade account filled with crazy stuff and a more stable large account and an IRA the stable large account and the IRA has barely budged and the E trade account has undergone a colonoscopy. The question is why? Is it the chip shortage> Partially. Is it the value of these tech stks for sure partially... But there seems to be something ese going on. Consider our fixation with the 10 year bond. That was such a joke anybody notice bong yield lately? It backed off a lot and yet the stks keep going down-- so that was cover, the market always seeks cover for what it wants to do... A HUGE rotation into heavy lifting I'm afraid.... Usually these cycles come through so quickly that by the time you figure out which larger stocks to buy the move is over and everyone is back in the high tech pool. Maybe not this time... We know that by the types of stks that were running NFT's --> Please! These various Bitcoin names and such... However I think the single biggest contributor to the market conditions is too many SPAC's and IPO's! Just too many. Something else-- remember stock picking as gambling and vice versa? Well some folks think the " Stimmy " checks this time are going straight into gambling and passing on the stock market.... That should ultimately be great news for the Draftkings of the world (MGM) but it has taken the buying power out of what is actually a very sleepy low vol market. The market should be going sideways not down and instead the Naz is going Down-- Where is the new money? 1/2 is in the big stocks and the other half is betting with BetMGM and others on the NCAA.... Something strange is happening in the stock market. Many have recently pointed to a Treasury yield hostage situation, where stocks have largely moves in response to their fixed-income counterparts. When bond yields moved up, high-growth names sold off, but even as the rates came down over the past three days, the tech sector was still under pressure. Some are even pointing to worries about the Fed hiking rates in far-off 2023, while others are mentioning frothy valuations and a rotation into industrial names, though trading volumes in the sector have also been softer in recent weeks. In fact, NYSE volumes have been 80% of the 30-day average, while Nasdaq activity has been 90% of its average, remarkably low given the declines in certain sectors. Another example: WSB/Reddit darling GameStop stumbled 34%after earnings on Wednesday, while only 23M shares changed hands, well short of the 30-day average of 34M shares. "It seems to show that the retail customer has walked away,"said Matt Maley from Miller Tabak. "The question is, why? Is it higher rates? Concerns about lockdowns? Or are they betting on March Madness?"
On recent equity flows:Hedge funds were net sellers for the first time in four weeks and sold by the biggest magnitude since mid-December. ENOB is up 25% in the pre! Enochian Bio rallies 29% on case report of complete remission in brain tumor Mar. 25, 2021 7:32 AM ETEnochian Biosciences, Inc. (ENOB) Enochian BioSciences(NASDAQ:ENOB), up 29% premarket and Seraph Research Institute (SRI) announce that a 36-year old patient with recurrent glioblastoma achieved completeremission for a period of 15 months. A complete remission response such as this is uncommon for this highly aggressive and deadly form of brain cancer. In compliance with FDA guidance, SRI treated the patient with natural killer (NK) and dendritic cells (DC) from a relative who had a partial genetic mismatch. The DCs were loaded with a component of cytomegalovirus that is known to be present in more than 90% of glioblastomas. Enochian is also developing this enhanced immune technology, including proof-of-concept in vivo studies of the potential to clear tumors with a focus on pancreatic cancer.
Toilet paper shortage could be next domino in global container ship crisis-! ArcBest tipped to see strong topline growth this year Mar. 25, 2021 7:10 AM ET ArcBest Corporation (ARCB) Morgan Stanley turns even more bullish on ArcBest(NASDAQ:ARCB)after meeting with management. Analyst Ravi Shanker: "Pension reform, solid fundamental sand mgmt. execution point to further upside from here. Macro tailwinds (low inventories, eCommerce proliferation, US manufacturing returning) and idiosyncratic growth opportunities (U-Pack, growing wallet share with existing customers) should support strong topline growth in 2021. While the driver shortage remains a challenge, it is also helping keep the market tight which should be supportive of pricing. Those gains plus a good line of sight to costs over the next two years and ongoing productivity initiatives means we believe margins can surprise positively." Shanker and team also think that the recent passage of the Butch Lewis Act, which provides funding for severely underfunded pensions, removes what has been a key overhang on the ARCB's trading multiple for years. MS affirms an Overweight rating on ArcBest and boosts its price target to $90 vs. theaverage Wall Street PT of $71.25.
One little bit of good news. The Health sector may still be OK. There was news out of Thermo Fisher yesterday which was huge. If you do not own that stock you probably should they have manufactured an air capture system that test for Covid in the air AND kind of captures it!!! This proof of concept is HUGE and will OPEN a new way of testing through the air large scale and on a smaller level boxes that can be brought into patients rooms and fire houses etc...
Ayr Strategies tapped by Needham for 2021 tally Dec. 23, 2020 7:21 AM ETAYR WELLNESS INC. (AYRWF) Needham keeps a Buy rating on Ayr Strategies (OTCQX:AYRWF)into 2021 as it factors in the company's recent acquisitionsin Florida and New Jersey. "AYR has an outstanding, but narrow, operating footprint at present, but with a feverish pace of M&A in recent months will see expansion into 5 new states. If integrated and operated to the standards set by Ayr assets in NV and MA, we expect these to be outstanding assets. That said, we would generously describe the FL asset as a 'fixer upper,' and note that growth in NJ is contingent upon facility expansion underway. Additionally, we point out that integration and execution risk increases with the number of markets being acquired." The firm notes that at a 7.5X EV/EBITDA multiple on its 2021 estimate, Ayr trades at 1/2 the multiple of peers. While execution risk is seen, Needham think the prospects for equity appreciation on growth and multiple re-rating are strong.
Ayr is a POT stock. Ayr Wellness: New Name, Same Game Mar. 16, 2021 11:26 AM ETAYR WELLNESS INC. (AYRWF)ACB, APHA, CGC... Summary Ayr Wellness is poised for substantial growth through 2022. The small MSO will quickly rival the size of global cannabis stocks with market valuations in excess of $10 billion. The stock trades at only 7.6x EV/2022 EBITDA target of $325 million.
--United Rentals price target raised to $370 from $355 at KeyBanc --Constellation Brands price target raised to $223 from $219 at Deutsche Bank » --Rite Aid price target raised to $27 from $17 at Deutsche Bank --Deutsche names Walgreens short-term buy idea, boosts price target --Bally's price target raised to $75 from $70 at Stifel » --Utz Brands price target raised to $30 from $26 at Citi 07:22 UTZ Citi analyst Wendy Nicholson raised the firm's price target on Utz Brands to $30 from $26 and keeps a Buy rating on the shares. The analyst expects Utz's fiscal 2021 results to largely fall in line with the company's guidance. --NuVasive price target raised to $80 from $68 at Citi 07:22 NUVA Citi analyst Joanne Wuensch raised the firm's price target on NuVasive to $80 from $68 and reiterates a Buy rating on the shares. NuVasive's acquisition of Simplify Medical underscores the artificial cervical disc replacement market's potential and the company's path to accelerate its recovery, Wuensch tells investors in a research note. The analyst believes the Simplify opportunity represents $10 to $14 per share. --Citi likes share setup for Vertex Pharmaceuticals, adds to Focus List »
Skillz sees Q1 revenue $80M, consensus $76.44M <---------- Wrap Technologies releases bodycam footage of BolaWrap use !!! My handlers have captured me a couple times just like this!
Powerful stuff. This company gets laughed at a lot and yea a guy running with a gun you don't want the Bolo but for every guy who's having a mental situation... all these people that have been killed in the past this item SHOULD be on every police officers hip. I still believe that. Kudos to these fine police officers for handling matters 100% correct That is Protecting And Serving. Is it that hard? - keep your cool -de escalate -everyone is a human